Takeda Pharmaceutical Real Estate Co, Ltd. and Takeda Pharmaceutical Company Limited have broken ground and begun construction for its Shin-Tokyo Takeda Bldg. The new building is part of the “Nihonbashi-honcho 2-chome Redevelopment Project” that the two companies are carrying out jointly with Mitsui Fudosan Co., Ltd. and which will become Takeda’s new Tokyo head office. Takeda is headquartered in Osaka, Japan.

The new building will stand 24 stories above ground and have four underground floors. It is scheduled to be completed in 2017, after which Takeda will establish it as the company’s new Tokyo head office in place of the current head office location at Nihonbashi 2-chome in Chuo-ku. The ground floor and second floor will be open for public use as a communal space, and tenants (shops) will be solicited for the B1 floor.

Source: Takeda